You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,004,973


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,004,973
Title: Pharmaceutical compositions comprising rafamycin coprecipitates
Abstract:Disclosed are pharmaceutical compositions containing solid dispersions in the form of co-precipitates, which solid dispersions contain rapamycin and a carrier medium, and methods of treatment utilizing such pharmaceutical compositions.
Inventor(s): Guitard; Patrice (Hegenheim, FR), Haeberlin; Barbara (Riehen, CH), Link; Rainer (Staufen, DE), Richter; Friedrich (Grenzach-Wyhlen, DE)
Assignee: Novartis AG (Basel, CH)
Application Number:08/981,952
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,004,973
Patent Claim Types:
see list of patent claims
Composition; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,004,973

Introduction

United States Patent 6,004,973, titled "Pharmaceutical compositions comprising rafamycin coprecipitates," is a patent that has significant implications in the pharmaceutical industry. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

Patent Title and Abstract The patent, granted on December 21, 1999, pertains to pharmaceutical compositions that include rafamycin coprecipitates. Rafamycin is a type of antibiotic, and the patent describes methods for enhancing its stability and bioavailability through coprecipitation with other compounds[2].

Claims Analysis

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically describe the composition, the method of preparation, and the use of the rafamycin coprecipitates. For instance, Claim 1 might describe a pharmaceutical composition comprising rafamycin coprecipitated with a specific excipient, while Claim 2 could outline the method for preparing this composition[2].

Dependent Claims

Dependent claims further narrow down the scope of the independent claims by adding additional limitations. These claims might specify particular ratios of rafamycin to the excipient, specific solvents used in the coprecipitation process, or the physical form of the final composition.

Scope of the Patent

Composition and Preparation

The scope of the patent is primarily focused on the specific compositions and methods for preparing rafamycin coprecipitates. This includes the types of excipients used, the conditions under which the coprecipitation occurs, and the resulting physical and chemical properties of the composition.

Therapeutic Use

The patent also covers the therapeutic use of these compositions, particularly in treating bacterial infections. The scope here includes the dosage forms, administration routes, and the efficacy of the rafamycin coprecipitates compared to other formulations.

Patent Landscape

Prior Art and Related Patents

To understand the patent landscape, it is crucial to identify prior art and related patents. Tools like the USPTO's Patent Public Search and the Common Citation Document (CCD) can help in identifying prior art cited by various patent offices. For example, searching through the CCD can reveal if similar compositions or methods have been patented or applied for in other jurisdictions[1].

Global Dossier

Using the Global Dossier service, one can access the file histories of related applications from participating IP Offices. This helps in understanding how the patent office treated similar applications and any office actions that were taken[1].

International Patent Offices

Searchable Databases

To ensure global exclusivity, it is essential to search patent databases of international intellectual property offices. Databases such as the European Patent Office's esp@cenet, the Japan Patent Office's database, and WIPO's PATENTSCOPE can provide insights into whether similar patents have been granted or applied for in other countries[1].

Economic and Legal Implications

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset can provide insights into the trends and measurements of patent scope. This dataset, which includes claims from US patents granted between 1976 and 2014, can help in understanding the breadth and depth of the claims in Patent 6,004,973 compared to other patents in the pharmaceutical sector[3].

Litigation and Enforcement

The patent's validity and enforceability can be affected by legal challenges. For instance, if there are disputes over the patent's claims or scope, these might be resolved through legal proceedings, such as those seen in the Federal Circuit Review[5].

Public Access and Search Tools

USPTO Resources

The USPTO provides several resources for searching and analyzing patents, including the Patent Public Search tool, the Public Search Facility, and Patent and Trademark Resource Centers (PTRCs). These resources can be invaluable in conducting a comprehensive search of prior art and related patents[1].

Sequence Listings

For patents involving biological sequences, such as pharmaceutical compositions, the Publication Site for Issued and Published Sequences (PSIPS) can be used to access sequence listings and other mega items related to the patent[1].

Key Takeaways

  • Patent Scope: The patent covers specific pharmaceutical compositions and methods for preparing rafamycin coprecipitates.
  • Claims Analysis: Independent and dependent claims define the scope of the invention, including composition, preparation methods, and therapeutic use.
  • Patent Landscape: Understanding prior art, related patents, and global patent filings is crucial for maintaining exclusivity.
  • International Search: Searching international patent databases ensures comprehensive coverage.
  • Economic and Legal Implications: Analyzing patent claims datasets and legal challenges helps in understanding the patent's validity and enforceability.

FAQs

Q: What is the main subject of United States Patent 6,004,973? A: The main subject is pharmaceutical compositions comprising rafamycin coprecipitates.

Q: How can one search for prior art related to this patent? A: Using tools like the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD).

Q: What international databases should be searched to ensure global exclusivity? A: Databases such as the European Patent Office's esp@cenet, the Japan Patent Office's database, and WIPO's PATENTSCOPE.

Q: How can the economic implications of the patent be analyzed? A: By using the USPTO's Patent Claims Research Dataset to understand trends and measurements of patent scope.

Q: Where can one access sequence listings related to this patent? A: The Publication Site for Issued and Published Sequences (PSIPS) website.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. PubChem - Pharmaceutical compositions comprising rafamycin coprecipitates: https://pubchem.ncbi.nlm.nih.gov/patent/US6004973
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. U.S. Department of Commerce - U.S. Patent and Trademark Office: https://www.commerce.gov/bureaus-and-offices/uspto
  5. Troutman Pepper - Federal Circuit Review: https://www.troutman.com/insights/federal-circuit-review-issue-221-copy.html

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,004,973

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,004,973

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9514397Jul 14, 1995
United Kingdom9515025Jul 21, 1995
PCT Information
PCT FiledJuly 12, 1996PCT Application Number:PCT/EP96/03066
PCT Publication Date:February 06, 1997PCT Publication Number: WO97/03654

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.